Siflon Drugs Private Limited, a active private limited company, was established on 19 March 2010 in Hyderabad, Telangana, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U24232TG2010PTC067606. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹6.15 Cr and a paid-up capital of ₹6.15 Cr.
It upholds a active non-compliant status. Employing 46 professional, Its leadership includes Ananthaiah Rallapalli (Managing Director), Parvathi Rallapalli (Director), Swetha Rallapalli (Director). It holds ₹33.61 Cr open charges and ₹4.96 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.76 & 77, Manu Residency Mathri Nagar, Miyapur, Hyderabad, Telangana, 500050.
U24232TG2010PTC067606
067606
19 March 2010
₹6.15 Cr
₹6.15 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Siflon Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ananthaiah Rallapalli | Managing Director | 19 Mar 2010 | Current |
| Parvathi Rallapalli | Director | 19 Mar 2010 | Current |
| Swetha Rallapalli | Director | 19 Mar 2010 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Siflon Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 68399.27% increase. The company also saw a substantial fall in profitability, with a 512641.11% decrease in profit. The company's net worth Soared by an impressive increase of 15249.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Siflon Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹336,100,000.00
₹49,550,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2019 | Axis Bank Limited | ₹6.83 Cr | Open |
| 30 Jul 2015 | Axis Bank Limited | ₹25.00 Cr | Open |
| 30 Jul 2015 | Axis Bank Limited | ₹1.78 Cr | Open |
| 09 May 2011 | Oriental Bank Of Commerce | ₹4.96 Cr | Satisfied |
Explore comprehensive loan charge details -
Siflon Drugs has a workforce of 46 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Siflon Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siflon Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Axis Bank Limited of Rs. 6.83 Cr registered on 22 Mar 2019 with Charge ID 100254464 was modified on 27 Jan 2025. was recorded as a recent event.
Progress on Siflon Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Siflon Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Progress on A charge with Axis Bank Limited of Rs. 1.78 Cr registered on 30 Jul 2015 with Charge ID 10588407 was modified on 29 Jul 2020. was documented.
The activity A charge with Axis Bank Limited amounted to Rs. 6.83 Cr with Charge ID 100254464 was registered on 22 Mar 2019. was completed.
Progress on A charge with Axis Bank Limited of Rs. 25.00 Cr registered on 30 Jul 2015 with Charge ID 10588447 was modified on 08 Mar 2018. was documented.
The CIN of Siflon Drugs Private Limited is U24232TG2010PTC067606.
Siflon Drugs Private Limited is headquartered at Plot No.76 & 77, Manu Residency Mathri Nagar, Miyapur, Hyderabad, Telangana, 500050.
Siflon Drugs Private Limited was incorporated on 19 March 2010.
The current directors of Siflon Drugs Private Limited are
The primary industry of Siflon Drugs Private Limited is Manufacturing.
Siflon Drugs Private Limited is unlisted.
The authorized capital of Siflon Drugs Private Limited is ₹6.15 Cr, and the paid-up capital is ₹6.15 Cr.
The compliance status of Siflon Drugs Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX